Rtw Investments Portfolio
Growth & qualityRTW INVESTMENTS, LP 13F holdings · Q3 2026 vs Q2 2026
Why growth & quality: 83 holdings, 30 effective · top 10 48% · turnover 17% a quarter · earnings yield -3.2% (median 2.9%) · 8 Schedule 13D filings, 0% of the book · 48 quarters of 13Fs
- 13F value
- $9.9bn−15.3% vs $11.7bn in Q2 2026
- Holdings
- 77 12 new · 9 sold out
- Top 10 weight
- 43.4% Largest: PTGX 7.2%
- Bought est.
- $614m New positions and adds
- Sold est.
- $1.8bn Trims and exits
- Quarter
- Q3 2026 Filed
Largest trades since Q2 2026
Estimated dollars: the change in shares times the quarter-end price the filing implies. Exits use last quarter's value.
| Action | Stock | Shares | Est. traded | Weight | Other gurus |
|---|---|---|---|---|---|
| Trimmed | MDGLMADRIGAL PHARMACEUTICALS INC | −84.3% | −$847m | 9.1% → 1.6% | 2 |
| Trimmed | PTCTPTC THERAPEUTICS INC | −79.1% | −$397m | 5.4% → 1.1% | 1 |
| Trimmed | INSMINSMED INC | −36.1% | −$199m | 4.4% → 3.6% | 7 |
| Trimmed | NTRANATERA INC | −40.0% | −$165m | 2.3% → 2.5% | 4 |
| Added | IRTCIRHYTHM HOLDINGS INC | +42.9% | +$106m | 2.2% → 3.6% | 2 |
| New | VRDNVIRIDIAN THERAPEUTICS INC | New | +$101m | 0.0% → 1.0% | 6 |
| Added | ZLABZAI LAB LTD | +57.5% | +$99m | 1.1% → 2.7% | 4 |
| Added | ERASERASCA INC | +25.1% | +$66m | 2.8% → 3.3% | 3 |
| Trimmed | SYRESPYRE THERAPEUTICS INC | −13.2% | −$50m | 3.2% → 3.3% | 3 |
| Trimmed | NBIXNEUROCRINE BIOSCIENCES INC | −25.7% | −$46m | 1.8% → 1.3% | 4 |
| Trimmed | CADLCANDEL THERAPEUTICS INC | −50.0% | −$34m | 0.6% → 0.3% | 0 |
| New | KRSAKORSANA BIOSCIENCES INC | New | +$28m | 0.0% → 0.3% | 5 |
| Added | RGENREPLIGEN CORP | +11.7% | +$28m | 1.4% → 2.7% | 2 |
| Added | AXGNAXOGEN INC | +64.0% | +$27m | 0.4% → 0.7% | 2 |
| Added | GPCRSTRUCTURE THERAPEUTICS INC | +42.0% | +$21m | 0.7% → 0.7% | 5 |
| Sold out | DFTXDEFINIUM THERAPEUTICS INC | −100.0% | −$19m | 0.2% → 0.0% | — |
| New | PYXSPYXIS ONCOLOGY INC | New | +$15m | 0.0% → 0.2% | 2 |
| Trimmed | RDNTRADNET INC | −4.5% | −$15m | 2.6% → 3.2% | 0 |
| Added | REPLREPLIMUNE GROUP INC | +14.6% | +$14m | 0.7% → 1.1% | 3 |
| Sold out | IDYAIDEAYA BIOSCIENCES INC | −100.0% | −$14m | 0.1% → 0.0% | — |
| New | SRZNSURROZEN INC | New | +$13m | 0.0% → 0.1% | 1 |
| New | FRNMFREENOME INC | New | +$12m | 0.0% → 0.1% | 4 |
| New | LTGOLATIGO BIOTHERAPEUTICS INC | New | +$12m | 0.0% → 0.1% | 2 |
| Added | RAREULTRAGENYX PHARMACEUTICAL IN | +9.4% | +$11m | 2.2% → 1.3% | 3 |
| Trimmed | EVMNEVOMMUNE INC | −86.1% | −$11m | 0.2% → 0.0% | 3 |
| Sold out | ATAIATAIBECKLEY INC | −100.0% | −$11m | 0.1% → 0.0% | — |
| Added | LRMRLARIMAR THERAPEUTICS INC | +126.8% | +$10m | 0.1% → 0.2% | 1 |
| Sold out | TENXTENAX THERAPEUTICS INC | −100.0% | −$10m | 0.1% → 0.0% | — |
| Added | TARSTARSUS PHARMACEUTICALS INC | +3.8% | +$10m | 1.8% → 2.8% | 3 |
| New | SLNSILENCE THERAPEUTICS PLC | New | +$7.7m | 0.0% → 0.1% | 3 |
| Sold out | FDMT4D MOLECULAR THERAPEUTICS IN | −100.0% | −$6.3m | 0.1% → 0.0% | — |
| Sold out | MAZEMAZE THERAPEUTICS INC | −100.0% | −$6.3m | 0.1% → 0.0% | — |
| New | ADRXADARX PHARMACEUTICALS INC | New | +$6.0m | 0.0% → 0.1% | 2 |
| New | DYNDYNE THERAPEUTICS INC | New | +$4.8m | 0.0% → 0.0% | 5 |
| New | RGNXREGENXBIO INC | New | +$4.2m | 0.0% → 0.0% | 2 |
| Added | NGNENEUROGENE INC | +11.0% | +$4.2m | 0.4% → 0.4% | 1 |
| Added | TNGXTANGO THERAPEUTICS INC | +1.1% | +$3.7m | 3.7% → 3.5% | 7 |
| Sold out | AVTXAVALO THERAPEUTICS INC | −100.0% | −$3.2m | 0.0% → 0.0% | — |
| Added | CMPSCOMPASS PATHWAYS PLC | +2.3% | +$3.1m | 1.3% → 1.4% | 0 |
| Trimmed | HTFLHEARTFLOW INC | −15.3% | −$2.2m | 0.1% → 0.1% | 1 |
| Added | ARGXARGENX SE | +0.3% | +$2.1m | 5.6% → 6.9% | 2 |
| Sold out | IMAIMAGENEBIO INC | −100.0% | −$2.0m | 0.0% → 0.0% | — |
| Trimmed | LMRILUMEXA IMAGING HOLDINGS INC | −23.1% | −$1.5m | 0.1% → 0.1% | 0 |
| Added | XNCRXENCOR INC | +0.7% | +$1.2m | 0.9% → 1.7% | 4 |
| New | OBXOBSIDIAN THERAPEUTICS INC | New | +$930k | 0.0% → 0.0% | 4 |
| Sold out | XGNEXAGEN INC | −100.0% | −$907k | 0.0% → 0.0% | — |
| New | LXEOLEXEO THERAPEUTICS INC | New | +$808k | 0.0% → 0.0% | 4 |
| Added | VSTMVERASTEM INC | +1.2% | +$662k | 0.2% → 0.5% | 0 |
| Added | SLDBSOLID BIOSCIENCES INC | +1.1% | +$477k | 0.3% → 0.4% | 2 |
| Trimmed | BBNXBETA BIONICS INC | −0.1% | −$22k | 0.2% → 0.2% | 2 |
All holdings 77 identified, plus $714m in securities without a listed ticker
Click a column to sort. Values are as reported at quarter-end, not today's prices.
| # | Stock | Shares | ||||
|---|---|---|---|---|---|---|
| 1 | PTGXPROTAGONIST THERAPEUTICS INC | $713m | 5,061,175 | Unchanged | 4 | |
| 2 | ARGXARGENX SE | $682m | 711,584 | +0.3% | 2 | |
| 3 | CGONCG ONCOLOGY INC | $604m | 8,514,590 | Unchanged | 1 | |
| 4 | IRTCIRHYTHM HOLDINGS INC | $354m | 3,118,913 | +42.9% | 2 | |
| 5 | INSMINSMED INC | $353m | 3,096,545 | −36.1% | 7 | |
| 6 | TNGXTANGO THERAPEUTICS INC | $351m | 14,048,477 | +1.1% | 7 | |
| 7 | ERASERASCA INC | $329m | 22,446,754 | +25.1% | 3 | |
| 8 | SYRESPYRE THERAPEUTICS INC | $329m | 3,691,791 | −13.2% | 3 | |
| 9 | RDNTRADNET INC | $319m | 4,630,697 | −4.5% | — | |
| 10 | TARSTARSUS PHARMACEUTICALS INC | $274m | 3,484,066 | +3.8% | 3 | |
| 11 | ZLABZAI LAB LTD | $273m | 10,350,973 | +57.5% | 4 | |
| 12 | RGENREPLIGEN CORP | $266m | 1,385,398 | +11.7% | 2 | |
| 13 | GHGUARDANT HEALTH INC | $264m | 1,481,033 | Unchanged | 6 | |
| 14 | CELCCELCUITY INC | $263m | 3,304,903 | Unchanged | 4 | |
| 15 | ORKAORUKA THERAPEUTICS INC | $261m | 3,139,030 | Unchanged | 5 | |
| 16 | NTRANATERA INC | $248m | 600,000 | −40.0% | 4 | |
| 17 | CYTKCYTOKINETICS INC | $189m | 2,862,003 | Unchanged | 4 | |
| 18 | XNCRXENCOR INC | $170m | 6,827,461 | +0.7% | 4 | |
| 19 | MDGLMADRIGAL PHARMACEUTICALS INC | $158m | 312,817 | −84.3% | 2 | |
| 20 | IMCRIMMUNOCORE HLDGS PLC | $148m | 4,869,798 | Unchanged | 4 | |
| 21 | STOKSTOKE THERAPEUTICS INC | $146m | 5,623,525 | Unchanged | 4 | |
| 22 | ACADACADIA PHARMACEUTICALS INC | $144m | 7,144,524 | Unchanged | 2 | |
| 23 | KODKODIAK SCIENCES INC | $141m | 1,487,934 | Unchanged | 3 | |
| 24 | CMPSCOMPASS PATHWAYS PLC | $136m | 10,948,591 | +2.3% | — | |
| 25 | NBIXNEUROCRINE BIOSCIENCES INC | $134m | 942,684 | −25.7% | 4 | |
| 26 | RAREULTRAGENYX PHARMACEUTICAL IN | $128m | 8,529,394 | +9.4% | 3 | |
| 27 | KLRAKAILERA THERAPEUTICS INC | $123m | 10,776,820 | Unchanged | 2 | |
| 28 | BLTEBELITE BIO INC | $121m | 715,332 | Unchanged | 2 | |
| 29 | REPLREPLIMUNE GROUP INC | $112m | 8,491,525 | +14.6% | 3 | |
| 30 | IMVTIMMUNOVANT INC | $107m | 3,177,849 | Unchanged | 5 | |
| 31 | PTCTPTC THERAPEUTICS INC | $105m | 1,615,819 | −79.1% | 1 | |
| 32 | VRDNVIRIDIAN THERAPEUTICS INC | $101m | 4,910,126 | New | 6 | |
| 33 | CSTLCASTLE BIOSCIENCES INC | $99m | 2,778,335 | Unchanged | 1 | |
| 34 | COGTCOGENT BIOSCIENCES INC | $74m | 2,309,021 | Unchanged | 7 | |
| 35 | GPCRSTRUCTURE THERAPEUTICS INC | $71m | 2,282,138 | +42.0% | 5 | |
| 36 | AXGNAXOGEN INC | $70m | 1,659,376 | +64.0% | 2 | |
| 37 | TSHATAYSHA GENE THERAPIES INC | $66m | 13,560,258 | Unchanged | 5 | |
| 38 | OBIOORCHESTRA BIOMED HLDGS INC | $59m | 9,556,063 | Unchanged | 1 | |
| 39 | VSTMVERASTEM INC | $54m | 6,718,081 | +1.2% | — | |
| 40 | DHRDANAHER CORP DEL | $51m | 230,000 | Unchanged | 23 | |
| 41 | HNGEHINGE HEALTH INC | $49m | 500,000 | Unchanged | 2 | |
| 42 | RCKTROCKET PHARMACEUTICALS INC | $47m | 17,687,772 | Unchanged | 2 | |
| 43 | SLDBSOLID BIOSCIENCES INC | $43m | 5,905,426 | +1.1% | 2 | |
| 44 | NGNENEUROGENE INC | $42m | 1,512,456 | +11.0% | 1 | |
| 45 | CGEMCULLINAN THERAPEUTICS INC | $36m | 2,364,347 | Unchanged | 3 | |
| 46 | AQSTAQUESTIVE THERAPEUTICS INC | $34m | 7,426,471 | Unchanged | — | |
| 47 | CADLCANDEL THERAPEUTICS INC | $34m | 3,211,008 | −50.0% | — | |
| 48 | AKTSAKTIS ONCOLOGY INC | $31m | 1,592,043 | Unchanged | 3 | |
| 49 | SVRASAVARA INC | $31m | 5,952,380 | Unchanged | 4 | |
| 50 | KRSAKORSANA BIOSCIENCES INC | $28m | 877,020 | New | 5 | |
| 51 | KYMRKYMERA THERAPEUTICS INC | $27m | 240,000 | Unchanged | 3 | |
| 52 | DNTHDIANTHUS THERAPEUTICS INC | $22m | 248,063 | Unchanged | 5 | |
| 53 | BBNXBETA BIONICS INC | $19m | 998,855 | −0.1% | 2 | |
| 54 | LRMRLARIMAR THERAPEUTICS INC | $19m | 5,820,891 | +126.8% | 1 | |
| 55 | PYXSPYXIS ONCOLOGY INC | $15m | 6,506,229 | New | 2 | |
| 56 | IPSCCENTURY THERAPEUTICS INC | $15m | 8,695,652 | Unchanged | 2 | |
| 57 | BEAMBEAM THERAPEUTICS INC | $14m | 570,394 | Unchanged | 1 | |
| 58 | SRZNSURROZEN INC | $13m | 393,560 | New | 1 | |
| 59 | HTFLHEARTFLOW INC | $12m | 250,000 | −15.3% | 1 | |
| 60 | FRNMFREENOME INC | $12m | 742,500 | New | 4 | |
| 61 | LTGOLATIGO BIOTHERAPEUTICS INC | $12m | 700,000 | New | 2 | |
| 62 | SLNSILENCE THERAPEUTICS PLC | $7.7m | 700,000 | New | 3 | |
| 63 | OCGNOCUGEN INC | $6.9m | 6,666,666 | Unchanged | — | |
| 64 | MISTMILESTONE PHARMACEUTICALS IN | $6.8m | 7,833,336 | Unchanged | 1 | |
| 65 | ADRXADARX PHARMACEUTICALS INC | $6.0m | 300,000 | New | 2 | |
| 66 | ALLOALLOGENE THERAPEUTICS INC | $5.2m | 3,250,000 | Unchanged | 1 | |
| 67 | LMRILUMEXA IMAGING HOLDINGS INC | $5.1m | 500,000 | −23.1% | — | |
| 68 | DYNDYNE THERAPEUTICS INC | $4.8m | 300,000 | New | 5 | |
| 69 | RGNXREGENXBIO INC | $4.2m | 555,555 | New | 2 | |
| 70 | KLRSKALARIS THERAPEUTICS INC | $3.8m | 1,300,000 | Unchanged | — | |
| 71 | ABVXABIVAX SA | $2.6m | 26,400 | Unchanged | 6 | |
| 72 | MDLNMEDLINE INC | $2.4m | 70,000 | Unchanged | 8 | |
| 73 | CAPRCAPRICOR THERAPEUTICS INC | $2.4m | 250,000 | Unchanged | 3 | |
| 74 | IRONDISC MEDICINE INC | $2.0m | 30,000 | Unchanged | 6 | |
| 75 | EVMNEVOMMUNE INC | $1.7m | 208,071 | −86.1% | 3 | |
| 76 | OBXOBSIDIAN THERAPEUTICS INC | $930k | 67,706 | New | 4 | |
| 77 | LXEOLEXEO THERAPEUTICS INC | $808k | 239,149 | New | 4 |
Closest portfolios
Overlap is the weight two books have in common: for each shared stock, the smaller of the two weights, summed.
- TCG Crossover Management22.7%21 shared · CGON, TNGX, SYRE, ZLAB
- Paradigm Biocapital Advisors21.3%11 shared · INSM, TNGX, SYRE, TARS
- Perceptive Advisors15.1%22 shared · SYRE, CELC, PTGX, ORKA
- Avoro Capital Advisors13.8%10 shared · ARGX, CYTK, MDGL, CELC
- Baker Bros. Advisors12.5%21 shared · INSM, CELC, MDGL, ACAD
- Farallon Capital Management9.8%13 shared · PTGX, NTRA, IMVT, TNGX
- Deerfield Management8.1%11 shared · CELC, TNGX, COGT, STOK
- Frazier Life Sciences Management7.9%11 shared · ERAS, TARS, ZLAB, ACAD
- Bvf5.9%8 shared · XNCR, STOK, IMCR, GPCR
- Castle Hook Partners5.4%4 shared · NTRA, INSM, DHR, SVRA
Only here
The largest holdings no other tracked guru owns.
- RDNTRADNET INC3.2%
- CMPSCOMPASS PATHWAYS PLC1.4%
- VSTMVERASTEM INC0.5%
- AQSTAQUESTIVE THERAPEUTICS INC0.3%
- CADLCANDEL THERAPEUTICS INC0.3%
- OCGNOCUGEN INC0.1%
- LMRILUMEXA IMAGING HOLDINGS INC0.1%
- KLRSKALARIS THERAPEUTICS INC0.0%
A 13F is a filing, not a live portfolio. It lists US-listed long stock positions at quarter-end, and it arrives up to 45 days later. Cash, shorts, bonds, options and foreign listings are not in it. Trade sizes here are estimates from the change in share count, restated for stock splits.
Snapshot refreshed